Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01987310
What this trial is testing

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sheba Medical Center
Not applicableLooking for participantsNCT05332613
What this trial is testing

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Weill Medical College of Cornell University 40
Testing effectiveness (Phase 2)Study completedNCT05591079
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Cascade Pharmaceuticals, Inc 99
Not applicableUnknownNCT05422092
What this trial is testing

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Post-approval studies (Phase 4)Looking for participantsNCT06449833
What this trial is testing

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Who this might be right for
Type2 Diabetes MellitusNonalcoholic Fatty Liver Disease
Zhujiang Hospital 100
Very early researchStudy completedNCT02289235
What this trial is testing

Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM

Who this might be right for
Fatty LiverDiabetes Mellitus, Type 2
Shiraz University of Medical Sciences 76
Not applicableLooking for participantsNCT05766449
What this trial is testing

Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

Who this might be right for
Chronic Hepatitis bNon-alcoholic Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1,000
Not applicableUnknownNCT05556135
What this trial is testing

Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
Renal Impairment
Assiut University 90
Testing effectiveness (Phase 2)Study completedNCT02316717
What this trial is testing

A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Immuron Ltd. 133
Testing effectiveness (Phase 2)WithdrawnNCT02769091
What this trial is testing

A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes

Who this might be right for
Nonalcoholic SteatohepatitisType 2 Diabetes Mellitus
Teva Branded Pharmaceutical Products R&D, Inc.
Not applicableLooking for participantsNCT00575133
What this trial is testing

Prospective Cohort Study in Patients With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Zurich 150
Testing effectiveness (Phase 2)Study completedNCT04330326
What this trial is testing

Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
ScandiBio Therapeutics AB 32
Post-approval studies (Phase 4)Ended earlyNCT02365233
What this trial is testing

Fatty Liver Study in Patients With Type II Diabetes

Who this might be right for
Type II DiabetesNonalcoholic Fatty Liver
The University of Texas Medical Branch, Galveston 5
Testing effectiveness (Phase 2)Looking for participantsNCT06599918
What this trial is testing

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

Who this might be right for
Fatty LiverObesityHepatic Fibrosis+3 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Large-scale testing (Phase 3)UnknownNCT00658164
What this trial is testing

Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores

Who this might be right for
Nonalcoholic Fatty Liver Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 150
Not applicableUnknownNCT01139632
What this trial is testing

The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseCoronary Artery Disease
Ziv Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01094158
What this trial is testing

Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisMetabolic Syndrome
Galmed Medical Reserch 60
Testing effectiveness (Phase 2)Study completedNCT00501592
What this trial is testing

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Who this might be right for
Diabetes Mellitus, Type IIFatty Liver
Intercept Pharmaceuticals 64
Not applicableStudy completedNCT05325398
What this trial is testing

Effect of Molecular Hydrogen in Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Comenius University 30
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Next Page
15